Skip to main content
Log in

Clinical pharmacological evaluation of aminopenicillins

Klinisch-pharmakologische Beurteilung von Aminopenicillin

  • Clinical Pharmacological Evaluation
  • Published:
Infection Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Summary

To establish the clinical value of antibiotics, clinical trials are necessary. Both bacteriological and clinical-pharmacological data are helpful when designing a proper clinical trial. The difference between amoxicillin and ampicillin preparations cannot be defined on pharmacokinetic grounds alone. The difference in absorption between ampicillin and either pivampicillin or bacampicillin shows the latter two to be superior.

Zusammenfassung

Um den klinischen Wert von Antibiotika zu beurteilen, sind klinische Versuche nötig. Sowohl bakteriologische als auch klinisch pharmakologische Daten unterstützen die Durchführung einer korrekten klinischen Studie. Der Unterschied zwischen Amoxicillin- und Ampicillin-Präparationen kann nicht auf pharmakokinetischer Basis allein definiert werden. In der Beurteilung der unterschiedlichen Resorption zwischen Ampicillin und Pivampicillin oder Bacampicillin hat sich das letztere als überlegen erwiesen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Mattie, H., van der Voet, G. B. Influence of aminopenicillins on bacterial growth kinetics in vitro in comparison with the antibacterial effect in vivo. Infection 7, Suppl. 5 (1979) 434–437.

    Google Scholar 

  2. Kunst, M. W., Mattie, H. Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected withEscherichia coli. J. Infect. Dis. 137 (1978) 391–402.

    Google Scholar 

  3. Bryant, R., Hood, A., Hood, C., Koenig, M. Factors affecting mortality of gram-negative rod bacteremia. Arch. Intern. Med. 127 (1971) 120–128.

    Google Scholar 

  4. Sjövall, J., Magni, L., Bergan, T. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin and amoxicillin. Antimicrob. Agents Chemother. 13 (1978) 90–96.

    Google Scholar 

  5. Bergan, T. Pharmacokinetic comparison of oral bacampicillin and parenteral ampicillin. Antimicrob Agents Chemother. 13 (1978) 971–974.

    Google Scholar 

  6. Maesen, F., Beeuwkes, H., Buytendijk, H., Stillaert, J. Ampicilline spiegels bij patienten na toediening van pivampicilline “per os” en van ampicilline per intramusculaire injectie. Acta Tuberc. Pneumol. Belg. 6 (1972) 510–515.

    Google Scholar 

  7. Kunst, M., Mattie, H. Absorption of pivampicillin in post-operative patients. Antimicrob. Agents Chemother. 8 (1975) 11–14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mattie, H., Meenhorst, P.L. Clinical pharmacological evaluation of aminopenicillins. Infection 7 (Suppl 5), S456–S457 (1979). https://doi.org/10.1007/BF01659770

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01659770

Keywords

Navigation